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of in*,erobaerver variability revealed an average r value of 0.97. The table 
fists Intreobserver variability using paired student's t-tsst. 
Initial Rending 0 month Rending 
Obo Palm Moan differ p value r value mean differ p value r value 
Obl 1.2 1 ,? .:0,0001 0,OR 1.5 <0.001 0.9g 
Oba 1,3 0,1' ,~0,04 0,OO -O,0 <0,175 0,09 
Oba 2.3 -1,0 <0,0t 0.9O -2.1 <0.001 0.gO 
Conclusions: The Inter- and Intmobs6rver variability data demonstrate 
only moderato differences In maaauram6nt feohnlquo over time, averaging 
16as than .~2 frame, The excellent reproducibility results Indicate that TIMI 
frame ~ount la n oultsble method for core laboratory analysis of roperfuslon, 
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of 8uoe~esful Rspeffullon? 
P,A, G~rbet, V,L, 8orabmsny, M,R, Oalosandm, D,M, O'Connor, Union 
M~morl~l Hosplf~l, ~/flmom, MD; Cenfo~or, leo,, Malvem R~: O~/m 
Unlmr~l~ Me#/~al Center, Ourrmm, NC, USA 
~,s¢~/ro~n¢l; Administration of antibodies against P,selecfln poor fo raper. 
fusion can reduce infamt size, and improve thrembolysts in antm~l models, 
We defined fha eftsot8 of thrembotyllc therapy on the piatalat expression 
and plasma level8 of P.soloctin following attempted raporfuslon, and corm, 
Isled rheas dots with the clinical outcomes in patients with aoufe myocardial 
Interstice (AMI), 
Metho~ ancl R~ults: Plstelat.pound end soluble P,selectln were men- 
Itomd at praape¢lfled time points In 23 patients, enrolled In the GUSTO.Ill 
trial Failure to repoduso (n ~ 3) and reourmnf Is~homla (n - 2) were observed 
in 5 patients who subsequently undon,~nt emergency angioplsery, Ei,lhteen 
patients ware successfully reperfused, Plasma levels of P.seleotln ~um con- 
slstentty at loser twice higher in AMI patients, irrespective of the success of 
fhrembotytlo therapy, when compared with healthy controls, An Incresse of 
plasma P-sol . in levels was observed af 3 hours after ct~r¢easful threm, 
boty~ls (p ,= 0,002) end wee followed by a decrease to the basut!ne value 
later after mperluslon, In contrast, those patients who failed to rep~,duse. 
expressed fiat patterns of soluble P-selectln levels during the first 24 hours 
after ett~mptsd thrembotysls. At baseline, plstelef P-selecttn was higher in 
the patients, who failed to reperfuse, ee compared to the succassfulty raper- 
fused group (p = 0,03), and to controls (p = 0,01). There were no substantial 
changes Of the platelet P-selectln expression within the AMI groups, how- 
ever, platstet P.solectln was higher in patients with failed repertusion, and 
this difference was significant at 24 hours (p = 0 04), 
Conclusion: Increased pt~tolet P-aetectln, and absence of an early nse 
in its sohible fraction after attempted reperfuslon may serve ae indicators 
Of unsuo~sdul corons~ thrembotyats in patients presenting with acute my- 
ocardial Infarction, 
• Importence of  Non.chest Pain Presentat ion on 
Short Term Outcomes In Acute Myo©ardlal 
Infamtlon 
G. Heumann, K, Oken, R, Pemy. UniversiTy of Fiends Health Science 
Center JacksonWtle. Ft., USA 
Current guidelines for managemem of acute myocardial toleration (AMI) are 
denved from large scale clinical trials utilizing only patients (pts) admitted to 
the hospital from the Emergency Department lED) with chest pain (CP) of 
supected tschemlc origin, The in-hospital outcomes of points diagnosed wuth 
AMI who do not present to the ED with CP are not known, We compared 
in-hospital outcomes of points admitted from the ED with CP with a discharge 
diagnosis of AMI versus non-CP pts with discharge diagnosis of AMI. 
Ft'esu/ts: During a 6 month period. 128 pts had a discharge diagnosis of 
AMI. Ninety.two (72%) were CP pte edmttted from the ED and 36 (28%) 
were non-CP pts. Of non.CP pls. 58% were admitted to a non-cardiology 
service and 44% had non-cardiac admitting diagnoses. Thirty one of 92 CP 
pts (33%) received acute interventional therapy compared to only 1 of 36 
non-CP pts (3%) (p = 0.0001), Life-threatening complications occurred in 28 
CP pts (32%) versl!s t9 non-CP p~, (53%) (p = 3.018). Six CP tots (7%) died 
in-hospital compared to 8 non-CP pts (22%) (p = 0,011), 
Conclusion: Non-CP pts with AMI represent an important but heretofore 
neglected group of in-hospital pts with AMI. Non-CP pts with AMI were 
significantly more Ilkety to have life-threatening complications, were less likely 
to receive acute inten/entional therapy and had higher in-hospital mortality. 
These findings suggest the need for the development of specific guidelines 
for the diagnosis and management of non-CP pts with AML 
1 ] A New Anglographlc Method to Calculate 
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Coronary Velocity & Its RMetlonshlp to Clinical 
Outcomes After Thrombolyele 
M, Gibson, A, Spamno, K, Ryan, M, Rlzzo, J, Moynlhnn, M. Kelley, 
S, Marble, 'I", Dodge, C,R Cannon, E, Bmunweld, For the TIM1106 
Investigators; Brigham & Women~ Hospital, Boston MA, USA 
The length of ooronaw ndodes tom) was measured In views that mlnlmg, od 
forashodanlng, & the time to travenle that length wee measured using the 
TIMI Frame CounV30 (= seconds) Io erdve at the (]CA velo~ty ((~n/u¢) 
at 90 mln, after thmmbolyale, TIMI 0/1 Flow had 8 velocity of 0 cm/m~, A 
QCA velocity was aaoerfnlnsd In g3,~% of ptl, ('/03/881), Vellxdtlu In the 
preaCheS & absence of clinical events In pts, randomlsed to TNK or d.PA In 
TIMI 10B were ne follows: 
En~po!gt Present Abnet p.wk, o 
Death In Hoop, S,S ~ T,S(n =~ 33) 9,0 ~ 8,t(n,~ 1'a0) 0.00? 
Death 30 Day ?,S ~ 9,1' (n ,, 30) tz,e ~ a,0 (n ,~ ?3t ) o0~ 
Recur. MI In Hoop. 9,1 ~ 6,6 in.  3t) a.8 ~ 8,1 in,= 1'~) NB 
Sh0¢k In Hemp, fi,S ~ e,0(n ~, el) S,9 ~ 8,1 (n = Tt~) 0,0048 
S0 Min, EF .~40% ?,1 :t ?,~ in.  89) 10,(1 ~. ?,3 (n ~ 4~1) 00001 
Oe~aINRoMl~hock 
or ~F ~40% In Heap,, ..... "t,~, ~ 't.3 ~n ~ 113) !g,tl ± 7,4 ~n ,, 4Q9) <0.0~5 
When the analysis was restflofed to open arfenes, the velocity was in, 
versely related to both an EF ,:40% (p = 0,0006) and the ~ ~nt  
(p =, 0,0002), 
Con~u,Won: QCA velocity is an eMImata of velocity which doe8 not nKlUlm 
Instrementafinn of fhe lesion & is related to clinical Outcomes in acute Mi, 
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I 1 '002'149]  Gender Baaed Inequit ies Among Payer Groups  
In Hospital  Resource Uti l ization for  Acute 
Myocardial  Infamtlon 
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In order to ascertain the influence of payer statue among men and women on 
hospital resource utilization for myocardial infamUon in the US. data among 
286,260 non.transtorred patients enrolled from June 1994 to January 1997 
in the National Registry of Myocardial Infection 2 were compared among 4 
payer groups, Logistic regression analyses (adjusted for age and race) were 
performed for the 5 categories t listed below; Cox proportional hazard ratio 
Was pedomled for mortality t and was adjusted for age, race, payer, priOr 
cardiac and medical history, cardiac risk factors, vital signs, Killip class. In 
each comparison, men served as the reference greun. 
Adjusted odds ration (95% CI) for hospital resource utilization by gender 
Women vs Men (referent group) 
Medicare Fee-for Sewlce HMO Medcaid 
N 178,455 70,326 27,318 I0,159 
CATH r 0.68(0.67-0,70) 0,88 {0.65=0.91) 0.86(0.8~-0,90) 096{0.79-O.93) 
PTCA t 0.79(0.77-0.81) 0.38(0,85-0.92) 0.84t0.78-0.69 ) 0.85(0.77-0.94) 
CABS t 0.58(0.56-0.60) 0.76(0.72-0.80} 0,70(0,64..0.76) 0.gO(0.79-1,03) 
Acute RT t 0,68 (0,65-.0,71) 0,73 (0,6&-0,79} 0,76 (0,68-0,85) 0,75 (0,63-0,68) 
Consult t 062 (061-0.63) 0.65 (0.62--0.68) 0.68 (0.64-0,?3) 0,75 (0.69-O.81) 
Mortality  1.05 tl,03, 1,08) 1.13 (1.05, 1.21) 1.23 (1.12, 1,36) 1,24 (1.08, 1.42) 
RT = (acute) repedusion therapy in ideal patients who presented within 12 hours of symp- 
toms. with ST elevation or LBBB. and no contraindications to IV thrombolysis; Consult = 
cardiology consult 
Conclusion: Gender based inequities exist in the utilization of h~pital 
resources, which was significantly lower among women (compared to men) 
within each payer group, and may ultimateJy reflect important differences in 
adjusted hospital mortality. 
